Stay updated on Inhaled Imatinib for PAH Clinical Trial
Sign up to get notified when there's something new on the Inhaled Imatinib for PAH Clinical Trial page.

Latest updates to the Inhaled Imatinib for PAH Clinical Trial page
- Check7 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check14 days agoChange DetectedIMPAHCT study status updated to Terminated. The page notes that AV-101 (inhaled imatinib) did not demonstrate efficacy at the tested doses.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedRevision tag updated from v3.4.1 to v3.4.2; this appears to be a minor site maintenance update with no changes to study data or page functionality.SummaryDifference0.1%

- Check36 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1. This appears to be a minor site update with no changes to study content or user-facing information.SummaryDifference0.1%

- Check37 days agoChange DetectedThe page shows a new Revision: v3.4.1 label, replacing the previous Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check44 days agoChange DetectedThe page now includes a glossary toggle and updated metadata labels: 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', replacing the previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Inhaled Imatinib for PAH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled Imatinib for PAH Clinical Trial page.